2015-2019 Emerging Nucleic Acid Testing Assays, and Strategic Profiles of Leading Suppliers

July 2015 | 549 pages | ID: 2649E000110EN
Venture Planning Group

Abstracts

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables

Contents

Microbiology/Infectious Diseases
  a. Overview
  b. Major Infectious Diseases
    AIDS
    Structure and Composition
    Classification
    AIDS Origins
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
    Pathogenesis and Pathology
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
    Clinical Findings
    Plasma Viral Load
    Pediatric AIDS
    Neurologic Disease
    Opportunistic Infections
    Cancer
    Immunity
    Virus Isolation
    Serology
    Viral Nucleic Acid/Antigen Detection
    Epidemiology
    Worldwide Spread of AIDS
    United States
    Routes of Transmission
    DNA Probes
    Overview
    Quantitative PCR
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
    Adenovirus
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Adeno-Associated Viruses (AAV)
    Anthrax/Bacillus Anthracis
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Babesiosis
    Background
    BEA and Other Bartonella Diseases
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Chagas Disease
    Background
    Campylobacter
    Background
    Diagnostic Tests
    Culture Identification
    Vaccines and Drugs
    Chlamydia
    Background
    Chlamydia psittaci
    Chlmaydia pneumoniae
    Chlamydia trachomatis
    Diagnostic Tests
    Vaccines and Drugs
    Creutzfeldt-Jakob’s Disease
    Background
    Blood Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
    Bayer
    Disease Sciences/Bio Tec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
    Drugs
    Vaccines
    Cytomegalovirus
    Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
    Ebola Virus
    Background
    Epidemiology
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
    EchoVirus
    Background
    Acute Aseptic Meningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myopericarditis
    Neonatal Infections
    Diagnostic Tests
    Vaccines and Drugs
    Encephalitis
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Enteroviruses
    Background
    Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
    Vaccines and Drugs
    Epstein-Barr Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Gonorrhea
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Hepatitis
    Hepatitis A
    Hepatitis B
    Structure and Composition
    Replication
    Hepatitis C
    Hepatitis D (Delta)
    Hepatitis E
    Hepatitis G
    Hepatitis Infections Pathology
    Clinical Findings
    Laboratory Tests
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
    Virus-Host Immune Reactions
    Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta)
    Vaccines and Drugs
    Herpes Simplex Virus
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Legionella
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Lyme Disease
    Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
    Diagnostic Tests
    Vaccines and Drugs
    Malaria
    Mycoplasma
    Background
    Ureaplasma Urealyticum & Mycoplasma Hominis
    Diagnostic Tests
    Vaccines and Drugs
    Papillomaviruses/HPV
    Background
    HPV in Cancer
    Cervical Neoplasm
    Diagnostic Tests
    Vaccines and Drugs
    Prevention
    Parvovirus B19
    Background
    Microbiology
    Epidemiology
    Clinical Syndromes
    Erythema Infectiosum (Slapped Cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in Immunocompromised
    Perinatal Infections
    Diagnostic Test
    Vaccines and Drugs
    Pneumonia
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Polyomaviruses
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Salmonellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Shigellosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Streptococci
    Background
    Diagnostic Tests
    Vaccines and Drugs
Group A Streptococci
Group B Streptococci
    Toxoplasmosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Tuberculosis
    Background
    Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Skin Tests
    MDRTB
    Vaccines and Drugs
    West Nile Virus
    Background
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
    Yersinia
    Background
    Diagnostic Tests
    Vaccines and Drugs
    Antibiotic Susceptibility Cancer Testing
  a. Overview
  b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
  c. Oncogenes
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
Genetic Diseases
  a. Overview
  b. Nucleic Acid Amplification
  c. Chromosome Imaging
  d. Genomics Technologies
  e. Proteomics Technologies
  f. Current Pharmacogenomic Tests
  g. Future Pharmacogenomic Testing
  h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal-Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
  i. Social Issues and Concerns
Forensic Testing
  a. Overview
  b. Multilocus and Single Locus Probes
    Multilocus Probes
    Single Locus Probes
    PCR and RFLP
  c. The FBI
  d. DNA Profile Data Banks
    U.S.A.
    U.K.
  e. Judicial Implementation
  f. Major Crime Categories
  g. Factors Contributing to the DNA Probe Market Expansion
    Technology Availability
    Use of Hair as Evidence
  h. Wildlife Forensics
Paternity Testing/HLA Typing
Other Applications
  a. Disease Susceptibility Testing
  b. Cardiovascular Diseases
  c. Diabetes
  d. Alzheimer's Disease
  e. Periodontal Disease
  f. Plasma Purification
  g. Organ Transplantation
  h. Water Contamination
  i. Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Elitech Group
Eiken
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases